A detailed history of Mcf Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Mcf Advisors LLC holds 1 shares of DXCM stock, worth $75. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 13 92.31%
Holding current value
$75
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$64.0 - $116.06 $768 - $1,392
-12 Reduced 92.31%
1 $0
Q1 2024

Apr 16, 2024

BUY
$114.22 - $140.1 $114 - $140
1 Added 8.33%
13 $1,000
Q4 2023

Feb 01, 2024

SELL
$75.49 - $124.16 $301 - $496
-4 Reduced 25.0%
12 $1,000
Q4 2022

Jan 31, 2023

BUY
$84.98 - $122.67 $339 - $490
4 Added 33.33%
16 $1,000
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $475 - $930
7 Added 140.0%
12 $1,000
Q1 2022

May 05, 2022

BUY
$94.08 - $130.2 $470 - $651
5 New
5 $0
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $649 - $814
-5 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $533 - $715
5 New
5 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.